Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gates Foundation
Biotech
ProFound forms $35M preeclampsia pact with Gates Foundation
The biotech will use its vast repository of proteomics data to scour placental tissue for potential biomarkers and drug targets for preeclampsia.
Darren Incorvaia
Aug 27, 2026 6:30am
Addition Tx does the math and emerges from stealth with $100M
Dec 17, 2025 7:45am
Merck wades deeper into HIV PrEP waters with pair of trials
Jul 14, 2025 1:12pm
UPDATE: Judge temporarily blocks NIH grant changes in 22 states
Feb 10, 2025 11:30am
Gates invests in Immunocore to spur infectious disease R&D
Sep 18, 2017 7:50am
Ex-Amgen team nabs $14M from Merck, Gates Foundation for cheap biologics
Jul 25, 2016 12:01pm
